Trial Search Results
Blood and Marrow Transplant Clinical Research Network
The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.
Stanford is currently not accepting patients for this trial.
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator: Blood and Marrow Transplant Clinical Trials Network
- Drug: fluconazole
- Drug: voriconazole
- Procedure: bone marrow transplant
- Drug: thalidomide
- Drug: dexamethasone
Criteria for entry into a study varies by protocol
Ages Eligible for Study
2 Years - N/A
Genders Eligible for Study